3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
3
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Melanoma
29
Carcinoma, Renal Cell
18
Carcinoma, Non-Small-Cell Lung
13
Carcinoma, Hepatocellular
10
Brain Neoplasms
7
Skin Neoplasms
6
Neoplasm Metastasis
6
Neoplasms
5
Kidney Neoplasms
5
Colorectal Neoplasms
5
Clear-cell metastatic renal cell carcinoma
5
Squamous Cell Carcinoma of Head and Neck
4
Pancreatic Neoplasms
4
Lung Neoplasms
4
Carcinoma, Transitional Cell
4
Triple Negative Breast Neoplasms
3
Multiple Myeloma
3
Mesothelioma
3
Liver Neoplasms
3
Breast Neoplasms
3
Uveal Melanoma
2
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Sarcoma
2
Recurrence
2
Prostatic Neoplasms
2
Mycosis Fungoides
2
Mesothelioma, Malignant
2
Lymphoma, T-Cell
2
Lymphoma, Non-Hodgkin
2
Interventions
pembrolizumab
3
Temozolomide
3
Specimen Handling
3
Radiotherapy
2
peposertib
1
liposomal doxorubicin
1
gosha-jinki-gan
1
efineptakin alfa
1
cabozantinib
1
balstilimab
1
atezolizumab
1
abexinostat
1
Surgical Procedures, Operative
1
Radiation
1
ONC206
1
Magnetic Resonance Spectroscopy
1
Ipilimumab
1
Biopsy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Gliosarcoma
×
Ipilimumab
×
Clear all
NCT07134842
2026-04-09
WinGlio-ipi
University College, London
Phase 1
Recruiting
16 enrolled